Anti-microbial photodynamic therapy: useful in the future?

被引:0
作者
Tim Maisch
机构
[1] University of Regensburg,Department of Dermatology
来源
Lasers in Medical Science | 2007年 / 22卷
关键词
Anti-microbial photodynamic therapy; Oral bacteria; MRSA; Photosensitizer; Porphyrin-photosensitization;
D O I
暂无
中图分类号
学科分类号
摘要
Previous chapters in this volume have focused on fundamental principles and clinical applications of PDT. This chapter will attempt to outline emerging areas of research to identify some new applications that may become useful in the future in clinical practise. The worldwide rise in antibiotic resistance has driven research to the development of novel anti-microbial strategies. Cutaneous diseases caused by MRSA are ideally suited to treatment by anti-microbial photodynamic therapy for eradicating localized infections and for modulating wound healing due to the ability to deliver photosensitizer and light with topical application. The use of photosensitizer and light as an anti-microbial agent against periodontal microbial biofilms should also represent an attractive method of eliminating oral bacteria. Suitable light sources, laser light and non-coherent light will be briefly covered. This chapter will focus on some aspects of anti-microbial photodynamic therapy that appear to be promising for dermatological indications and inactivation of pathogenic bacteria within the oral cavity.
引用
收藏
页码:83 / 91
页数:8
相关论文
共 381 条
  • [21] Boehncke WH(1989)Lethal photosensitization for decontamination of implant surfaces in the treatment of peri-implantitis Br J Dermatol 121 51-350
  • [22] Sterry W(1996)Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure Cancer Chemother Pharmacol 37 343-104
  • [23] Kaufmann R(2006)Hypocrellins as photosensitizers for photodynamic therapy: a screening evaluation and pharmacokinetic study J Photochem Photobiol B 83 98-7
  • [24] Bytzer P(2002)Inactivation of methicillin-resistant Am J Clin Dermatol 3 1-115
  • [25] O’Morain C(2001) (MRSA) by liposome-delivered photosensitising agents Clin Infect Dis 32 108-1608
  • [26] Calzavara-Pinton PG(1999)Impact of increasing antimicrobial resistance on wound management Br J Cancer 79 1603-461
  • [27] Venturini M(1988)Vancomycin-intermediate and -resistant Br J Dermatol 119 445-265
  • [28] Sala R(2005): what the infectious disease specialist needs to know Lasers Surg Med 36 260-3909
  • [29] Carbon C(1997)Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of delta-aminolaevulinic acid Cancer Res 57 3904-488
  • [30] Chan Y(1995)Psoriasis Farmaco 50 479-57